Vitro Group
Vitro Group is a Spanish biotechnology company that develops, manufactures and commercializes integrated in-vitro diagnostic solutions — reagents, instruments and software — for anatomical pathology and molecular diagnostics, serving hospitals, clinical laboratories and health authorities across Iberia, Turkey, the U.S. and Latin America.
- Company typePrivate
- Founded1989
- HeadquartersMadrid, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vitro Group does
Vitro S.A. (trading as Vitro Group / Vitro Master Diagnóstica) is a privately held Spanish biotechnology company founded in 1989 and headquartered in Seville, with additional offices in Madrid, Lisbon and Istanbul (via Vitro Diagnostics Turkey LTD). The company develops, manufactures and commercializes integrated in-vitro diagnostic solutions across two principal divisions: anatomical pathology (immunohistochemistry, in situ hybridization, fluorescence in situ hybridization) and molecular diagnostics / microbiology (multiplex PCR and the proprietary DNA FLOW microarray platform). Its product portfolio spans reagents — including more than 300 immunohistochemistry antibody references and DNA FLOW kits covering HPV (35 genotypes), STD pathogens, respiratory agents, sepsis pathogens with antibiotic resistance markers, multidrug resistance, meningitis, tick-borne bacteria and tuberculosis — instruments (HybriSpot, VitroCycler, MAIS, Victoria V96, MD-Stainer, and the newly launched NeoPATH Pro), and software (the third-generation Anapath LIMS for anatomical pathology, OVTS workflow management, and Hybrisoft).
Revenue is generated through a mix of one-time reagent sales, hardware instrument sales, recurring software licenses and subscriptions (Anapath, Hybrisoft, OVTS), and professional services from an ENAC-accredited reference laboratory in Seville covering more than 300 m². The company holds an unusually broad certification stack — ISO 9001, 14001, 13485, 27001, 15189, UNE 166002, ANVISA GMP and CE-IVD marking — and distributes through a combination of direct sales in Iberia, Turkey and Latin America plus exclusive channel partners, most notably Biocare Medical for NeoPATH Pro in the United States and Getronics for Anapath deployment in Spanish hospitals. Leadership is anchored by CEO Ferrán Prat, with Miguel Viribay as Global Commercial Director.
Vitro Group firmographics
Firmographics- Name
- Vitro Group
- Legal name
- Vitro S.A.
- Website
- https://vitro.bio
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Vitro Group is a Spanish biotechnology company that develops, manufactures and commercializes integrated in-vitro diagnostic solutions — reagents, instruments and software — for anatomical pathology and molecular diagnostics, serving hospitals, clinical laboratories and health authorities across Iberia, Turkey, the U.S. and Latin America.
- Ownership category
- akta.pro rank
Vitro Group industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers) (HLAAAMAI), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Vitro Group is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices4 records
Markets served
Vitro Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Reagents: Sale of reagents for immunohistochemistry, molecular diagnostics including DNA FLOW and RT-PCR kits for infectious disease detection
- Instrumentation: Sale and distribution of diagnostic instruments including HybriSpot, VitroCycler, MAIS, Victoria V96, and NeoPATH Pro
- Software Licenses and Subscriptions: Anapath (LIS for pathology), Hybrisoft (analysis software), OVTS (workflow management) with ongoing support and updates
- Reference Laboratory Services: Accredited diagnostic services in anatomical pathology and microbiology provided through clinical reference laboratory covering over 300 m²
Go-to-market motion1 record
Distribution channels4 records
Marketing channels3 records
Vitro Group product offering
Product offeringCore offering
Vitro develops, manufactures, and commercializes integrated in-vitro diagnostic solutions combining reagents (IHC antibodies, DNA FLOW multiplex PCR/microarray kits, real-time PCR kits), proprietary instrumentation (HybriSpot, VitroCycler, MAIS, Victoria V96, MD-Stainer, NeoPATH Pro), and laboratory software (Anapath pathology LIMS, HYBRISOFT, OVTS). The offering targets anatomical pathology and molecular diagnostics/microbiology workflows for cancer and infectious disease detection in hospitals, reference laboratories, and health authorities.
Product overview
Vitro offers integrated diagnostic solutions for cancer diagnostics and infectious disease detection. The portfolio spans three product categories (reagents, instrumentation, software) across two main divisions: Anatomical Pathology (IHC, ISH, FISH testing) and Molecular Diagnostics/Microbiology (PCR, DNA FLOW technology). Key products include OVTS (workflow management), HYBRISOFT (HybriSpot management), real-time PCR kits (respiratory, HPV, STI, tuberculosis panels), DNA FLOW kits (HPV 35-genotype, STD 11-pathogen, respiratory 23-agent, sepsis 36-pathogen panels), and instruments (HybriSpot automation, VitroCycler, MAIS extraction, Victoria V96, NeoPATH Pro). The Anapath LIMS software serves anatomical pathology laboratories, while the reference laboratory provides accredited diagnostic testing services.
Differentiator
Problem solved
Functional benefit
Brands
- Anapath: Third generation Pathology Laboratory Information Management System (LIS) for anatomical pathology
- Ovts
- Hybrisoft
- HybriSpot
- VitroCycler
- MAIS
- Victoria V96
- MD-Stainer
- DNA Flow
Products and services
- HPV Direct Flow Chip Kit DNA FLOW kit enabling simultaneous detection of 35 HPV genotypes for cervical cancer screening; for clinical laboratories performing molecular diagnostics.
- STD Direct Flow Chip Kit DNA FLOW kit for detection of 11 sexually transmitted disease pathogens; for clinical microbiology laboratories.
- Respiratory Flow Chip Kit DNA FLOW kit for detection of 23 main infectious respiratory agents; for clinical microbiology and respiratory diagnostics laboratories.
- Sepsis Flow Chip Kit DNA FLOW kit for detection of 36 pathogens and 20 antibiotic resistance genes for sepsis diagnosis; for clinical microbiology laboratories and critical-care diagnostics.
- MDR Direct Flow Chip Kit DNA FLOW kit for detection of 5 bacterial species and 56 resistance markers for multidrug resistance identification; for clinical microbiology and antimicrobial stewardship programs.
- Bacterial CNS Flow Chip Kit DNA FLOW kit for detection of 9 bacteria and 1 fungus causing central nervous system infections such as meningitis and encephalitis; for clinical microbiology laboratories.
- Tick-Borne Bacteria Flow Chip Kit DNA FLOW kit for detection of 7 tick-borne bacterial genera (Anaplasma, Ehrlichia, Borrelia, Bartonella, Coxiella, Rickettsia, Francisella); for clinical microbiology and vector-borne disease diagnostics.
- RESPI+ RT-PCR Kit One-step real-time RT-PCR kit for detection of respiratory pathogens including RSV, MPV, and Rhinovirus; for clinical microbiology laboratories performing respiratory diagnostics.
- SARS-CoV-2 RT-PCR Kit Real-time PCR kit for detection of SARS-CoV-2 virus; for clinical microbiology and public-health diagnostic laboratories.
- Flu-Covid RT-PCR Kit Multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B; for clinical microbiology and respiratory diagnostic laboratories.
- HPV HR Screening Kit Real-time PCR kit for detection of high-risk HPV genotypes (16, 18, and 12 additional HR types) used in cervical cancer screening; for clinical laboratories performing women's-health diagnostics.
- HPV LR Screening Kit Real-time PCR kit for detection of low-risk HPV genotypes (6, 11, and 13 additional LR types); for clinical laboratories performing HPV diagnostics.
- STI CNM Kit Real-time PCR kit for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium; for clinical microbiology and STI diagnostic laboratories.
- MTBC-NTM Real Time PCR Kit Multiplex real-time PCR kit for simultaneous detection of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria species; for clinical microbiology and tuberculosis diagnostic laboratories.
- Respiplex (RSV-MPV-RhV) RT-PCR Multiplex real-time RT-PCR kit for detection of Respiratory Syncytial Virus, Metapneumovirus, and Rhinovirus; for clinical microbiology and respiratory diagnostic laboratories.
- Monkey Pox Detection Real-time PCR kit for detection of Monkey Pox virus; for clinical microbiology and public-health diagnostic laboratories.
- HybriSpot Instrument Automated molecular diagnostic platform for amplification, denaturation, and hybridisation using proprietary DNA FLOW technology; for clinical microbiology laboratories.
- VitroCycler Flexible real-time thermocycler with dedicated power supply and separate 6-zone temperature control for fast, accurate, and consistent quantitative fluorescence analyses; for clinical and research laboratories.
- MAIS (Molecular Automated Integral Solution) Fully automated nucleic acid extraction system from primary tube to eluate, compatible with various primary tube types and suitable for both high and low sample volume laboratories; for clinical microbiology laboratories.
- Victoria V96 Integrated automated pre-analytical and analytical instrument capable of uncapping/recapping tubes, rehydrating dry swabs, extracting nucleic acids, and preparing PCR plates; for clinical microbiology laboratories.
- MD-Stainer Automated staining platform for immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) with 36 positions, independent monitored reaction chambers, and capability to combine IHC and FISH within the same workflow; for anatomical pathology laboratories.
- NeoPATH Pro Instrument High-throughput platform with 42-slide capacity supporting advanced immunohistochemistry (IHC), in situ hybridisation (ISH), and fluorescence in situ hybridisation (FISH) for cancer diagnostics; for hospital and reference anatomical pathology laboratories.
- Anapath Pathology LIMS Third-generation Laboratory Information Management System (LIMS) for anatomical pathology, market leader in Spain and among the most advanced globally for digital transformation toward computational pathology; for hospital and reference anatomical pathology laboratories.
- HYBRISOFT Software Advanced management software for HybriSpot devices enabling sample management, image capture, and automated analysis and interpretation of results with two-way LIS connection; for clinical microbiology laboratories running HybriSpot.
- OVTS Workflow Management Software Laboratory workflow management module for identification and traceability of samples and automated interpretation of results, with two-way connectivity to the LIS; for clinical microbiology laboratories.
- Reference Laboratory Services Accredited clinical diagnostic laboratory providing microbiological and anatomical pathology services across more than 300 m² with highly qualified biomedical professionals, including second-opinion consultations; for healthcare professionals, medical institutions, and diagnostic centres.
Quantifiable outcome
- DNA FLOW technology reduces processing time from several hours to a few minutes
- +2 more outcomes
Companies that use Vitro Group
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Vitro Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature6 records
Vitro Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- GetronicscoreStrategic alliance for reinforcing Anapath expansion in the healthcare sector. Getronics assumed leadership in direct sales, support and implementation of laboratory information management solutions for Anatomical Pathology in hospitals and reference laboratories in Spain. Getronics brings over 135 years of international experience, more than 4,000 professionals, and presence in over 20 countries. The partnership supports Vitro's global operational development and efficiency plan.
- Biocare MedicalcoreVitro appointed Biocare Medical as the exclusive distributor for its NeoPATH Pro instrument in the United States. The NeoPATH Pro is a high-throughput platform with 42-slide capacity supporting advanced immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). The agreement leverages Biocare Medical's extensive expertise and established presence in advanced staining solutions, providing U.S. laboratories with enhanced local support, service, and access to innovative diagnostic technology. The product officially debuted at USCAP 2025.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Vitro Group competitors and assessment
Company assessmentEmerging players
- ELITechGroup: European-headquartered IVD company offering molecular PCR reagents and clinical chemistry instruments; similar mid-sized European IVD competitor with overlapping PCR and infectious-disease menu.
Regional players
- Grifols: Spanish-headquartered global diagnostics and plasma-derived-therapy company with clinical diagnostics offerings; relevant Iberian regional peer with comparable regulatory and reimbursement environment.
Broad incumbents
- Roche Diagnostics: Largest global IVD player spanning tissue diagnostics (Ventana) and molecular PCR; competes with Vitro's NeoPATH Pro in IHC/ISH/FISH and with the company's PCR menu in microbiology.
- Hologic (Molecular Diagnostics): Operates Panther/Panther Fusion molecular diagnostics systems with broad infectious-disease and women's-health assay menus; overlaps with Vitro's infectious-disease PCR kits and HPV screening reagents.
- bioMérieux (BioFire/bioMérieux): Leader in clinical microbiology diagnostics with FilmArray/BioFire syndromic panels and VITEK systems; competes directly with Vitro's DNA FLOW multiplex infectious-disease menu on sepsis and respiratory panels.
- Danaher (Cepheid / Leica Biosystems): Operates GeneXpert (Cepheid) for molecular diagnostics and Leica Biosystems for IHC/ISH/FISH pathology; broad incumbent whose two segments are the closest analogues to Vitro's instrument + reagent model.
- Agilent Technologies (Pathology & Molecular): Major provider of IHC/ISH/FISH pathology solutions and molecular reagents/instruments; closely comparable to Vitro's anatomical-pathology franchise and molecular diagnostics menu.
- Bio-Rad Laboratories: Global diagnostics and life science manufacturer with a sizable clinical diagnostics and IHC/ISH reagent business; highly comparable to Vitro's anatomical pathology reagent portfolio and IVD reagent catalog.
Direct peers
- Qiagen: Sample-to-answer molecular diagnostics provider with PCR reagent kits, automated extraction instruments and bioinformatics; directly overlaps with Vitro's VitroCycler, MAIS extraction and broad PCR reagent menu.
- Biocare Medical: U.S. specialty provider of advanced staining reagents and IHC instruments; Vitro's exclusive distribution partner for NeoPATH Pro in the U.S. and a direct comparably sized IHC-focused competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Vitro Group social profiles
Digital presenceVitro Group compliance and trust
Trust signalCompliance11 records
Vitro Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitro Group leadership team
Management profileNumber of profiles
Profiles5 records
Vitro Group subsidiaries and ownership
Company hierarchySubsidiaries2 records
Vitro Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitro Group M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitro Group
What does Vitro Group do?
Vitro develops, manufactures, and commercializes integrated in-vitro diagnostic solutions combining reagents (IHC antibodies, DNA FLOW multiplex PCR/microarray kits, real-time PCR kits), proprietary instrumentation (HybriSpot, VitroCycler, MAIS, Victoria V96, MD-Stainer, NeoPATH Pro), and laboratory software (Anapath pathology LIMS, HYBRISOFT, OVTS). The offering targets anatomical pathology and molecular diagnostics/microbiology workflows for cancer and infectious disease detection in hospitals, reference laboratories, and health authorities.
Is Vitro Group a public or private company?
Vitro Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vitro Group founded?
Vitro Group was founded in 1989. It employs 101 to 250 people.
Where is Vitro Group based?
Vitro Group is headquartered in Madrid, Spain, in the Europe region.
How does Vitro Group make money?
Four revenue lines are on record. Diagnostic Reagents are the primary driver. The others are instrumentation, software Licenses and Subscriptions and reference Laboratory Services.
Who are Vitro Group's main competitors?
ELITechGroup is listed as an emerging player. Grifols is listed as a regional player. Broad incumbents are Roche Diagnostics, Hologic (Molecular Diagnostics), bioMérieux (BioFire/bioMérieux), Danaher (Cepheid / Leica Biosystems), Agilent Technologies (Pathology & Molecular) and Bio-Rad Laboratories. Direct peers are Qiagen and Biocare Medical.
Does Vitro Group have an API?
No public API is recorded for Vitro Group.
What industry is Vitro Group in?
Vitro Group's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 325413 and its SIC code is 2835.